Peptide binding by class I and class II MHC molecules.

Major histocompatibility complex (MHC) antigens bind peptides of diverse sequences with high affinity. They do this in order to generate maximal immunological protection by covering the spectrum of peptides that may be seen by a host over the course of its lifetime. However, in many circumstances the immune system does not recognize a particular peptide that it should for maximum advantage over the pathogen. In other situations, the immune system goes awry and incorrectly recognizes a self-peptide that it should not. This results in disease characterized by recognition and attack of self. Rheumatoid arthritis is an example of just such a disease. In either of these situations, peptide-based modalities for immune therapy would be an advantage. However, peptide-based therapies require a thorough understanding of the forces involved in peptide binding. Great strides have been made in elucidating the mechanisms by which these MHC proteins may bind peptides with diverse sequences and high affinity. This review summarizes the current data obtained from crystallographic analyses of peptide binding for both class I and class II MHC molecules. Unfortunately, as yet these data have not allowed us to predict which peptides will bind with high affinity to a specific MHC molecule.

[1]  P. Marrack,et al.  The Repertoire of T Cells Shaped by a Single MHC/Peptide Ligand , 1996, Cell.

[2]  J. Sacchettini,et al.  The three-dimensional structure of H-2Db at 2.4 Å resolution: Implications for antigen-determinant selection , 1994, Cell.

[3]  P. Marrack,et al.  Production of soluble MHC class II proteins with covalently bound single peptides , 1994, Nature.

[4]  D I Stuart,et al.  Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. , 1996, Immunity.

[5]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[6]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[7]  Robyn L. Stanfield,et al.  An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.

[8]  D. Wiley,et al.  Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Rognan,et al.  Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[11]  P Bork,et al.  The immunoglobulin fold. Structural classification, sequence patterns and common core. , 1994, Journal of molecular biology.

[12]  D. Wiley,et al.  The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. A. Peterson,et al.  Antigen‐presenting Function of the Mouse CD1 Molecule a , 1996, Annals of the New York Academy of Sciences.

[14]  P. A. Peterson,et al.  Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[16]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[17]  A. Rudensky,et al.  Intracellular assembly and transport of endogenous peptide-MHC class II complexes. , 1994, Immunity.

[18]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[19]  Søren Buus,et al.  A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules , 1994, European journal of immunology.

[20]  G N Murshudov,et al.  The structural basis of sequence-independent peptide binding by OppA protein. , 1994, Science.

[21]  Craig M. Ogata,et al.  Structural Analysis of Substrate Binding by the Molecular Chaperone DnaK , 1996, Science.

[22]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[23]  D I Stuart,et al.  An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.

[24]  A. Clarke.  Molecular chaperones in protein folding and translocation. , 1996, Current opinion in structural biology.

[25]  J. Deisenhofer,et al.  Nonclassical binding of formylated peptide in crystal structure of the MHC class lb molecule H2-M3 , 1995, Cell.

[26]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[27]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[28]  Don C. Wiley,et al.  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.

[29]  P. Parham,et al.  A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.

[30]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[31]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[32]  D. Leahy,et al.  The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Edward J. Collins,et al.  Three-dimensional structure of a peptide extending from one end of a class I MHC binding site , 1994, Nature.

[34]  D. Wiley,et al.  Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Frelinger,et al.  Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[37]  D. Wiley,et al.  Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. , 1994, Science.

[38]  J. Howard.  Supply and transport of peptides presented by class I MHC molecules. , 1995, Current opinion in immunology.

[39]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[40]  J. Sacchettini,et al.  Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Wiley,et al.  Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Schreiber,et al.  Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Rowland-Jones,et al.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Grey,et al.  Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. , 1994, Journal of immunology.

[45]  J. Frelinger,et al.  A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. , 1996, Immunity.

[46]  J. Cook,et al.  The mechanisms of peptide exchange and beta 2-microglobulin exchange on cell surface Ld and Kb molecules are noncooperative. , 1996, Journal of immunology.

[47]  T. Elliott,et al.  Assembly of MHC class I molecules analyzed in vitro , 1990, Cell.

[48]  S. Schreiber,et al.  A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. , 1995, Chemistry & biology.

[49]  J. Freed,et al.  Comparison of peptides bound to spleen and thymus class II , 1993, The Journal of experimental medicine.

[50]  M. A. Saper,et al.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.

[51]  D. Wiley,et al.  The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide , 1992, Cell.

[52]  S. Rowland-Jones,et al.  Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. , 1994, Immunity.

[53]  P. Parham,et al.  Peptide binding to empty HLA-B27 molecules of viable human cells , 1991, Nature.

[54]  P. Bjorkman,et al.  Effects of peptide length and composition on binding to an empty class I MHC heterodimer. , 1994, Biochemistry.

[55]  B. Matthews,et al.  Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme. , 1995, Biochemistry.

[56]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[57]  I. Wilson,et al.  Structure of anti-peptide antibody complexes. , 1994, Research in immunology.

[58]  William S. Lane,et al.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.

[59]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[60]  H. Ploegh,et al.  Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes , 1995, The Journal of experimental medicine.

[61]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[62]  T. Watts,et al.  Molecular chaperones in antigen presentation. , 1995, Current opinion in immunology.

[63]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[64]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[65]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[66]  Mike Carson,et al.  Ribbon models of macromolecules , 1987 .

[67]  P. Allen,et al.  Dissection of the Hb(64-76) determinant reveals that the T cell receptor may have the capacity to differentially signal. , 1992, Advances in experimental medicine and biology.

[68]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[69]  P. Cresswell,et al.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.

[70]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.